The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide

被引:36
作者
Siddiqui, AH
Harris, AD
Hebden, J
Wilson, PD
Morris, JG
Roghmann, MC
机构
[1] VA Maryland Hlth Care Syst, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Healthcare Outcomes Res, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[4] Univ Maryland, Med Syst, Baltimore, MD 21201 USA
关键词
D O I
10.1067/mic.2002.118616
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Vancomycin-resistant enterococci (VRE) have become a major cause of nosocomial Infections and are now endemic in many geographic areas, The aim of this study was to describe the effect of active surveillance for patients with VRE in high-risk units on the VRE incidence rate hospital-wide. Methods: We determined 4 time periods based on the intervention of active surveillance: preactive surveillance (period 1), active surveillance (period 2), no active surveillance (period 3), and reinstutition of active surveillance (period 4). VRE incidence rates based on first clinical culture for VRE per 10,000 patient days for each of these periods and incidence rate ratios were then calculated. Results: Active surveillance in high-risk units was associated with a significant reduction in VRE incidence hospital-wide in 2 of the 3 comparisons made. The incidence rate ratio when comparing the first period of active surveillance (period 2) to the preactive surveillance period (period 1) was 0.63 (95 % Cl, 0.38-1.1) it was 0.36 (95 % Cl, 0.23-0.55) when comparing the first period of active surveillance (period 2) to the subsequent period (period 3) and 0.68 (95% Cl, 0.54-0.85) when comparing the second period of active surveillance (period 4) to the prior period without active surveillance periods, Conclusions: Active surveillance culturing for VRE in the high risk-units prevented further VRE transmission, as evidenced by a significant increase in hospital-wide incidence rates when active surveillance was discontinued and a significant decrease in incidence rates when it was restarted.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 14 条
  • [1] [Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
  • [2] [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597
  • [3] Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates
    Bodnar, UR
    Noskin, GA
    Suriano, T
    Cooper, I
    Reisberg, BE
    Peterson, LR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) : 2129 - 2132
  • [4] PREDOMINANT PATHOGENS IN HOSPITAL INFECTIONS
    JARVIS, WR
    MARTONE, WJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 : 19 - 24
  • [5] KARANFIL LV, 1992, INFECT CONT HOSP EP, V13, P195, DOI 10.1086/646509
  • [6] Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting
    Montecalvo, MA
    Jarvis, WR
    Uman, J
    Shay, DK
    Petrullo, C
    Rodney, K
    Gedris, C
    Horowitz, HW
    Wormser, GP
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) : 269 - 272
  • [7] ENTEROCOCCI RESISTANT TO MULTIPLE ANTIMICROBIAL AGENTS, INCLUDING VANCOMYCIN - ESTABLISHMENT OF ENDEMICITY IN A UNIVERSITY MEDICAL-CENTER
    MORRIS, JG
    SHAY, DK
    HEBDEN, JN
    MCCARTER, RJ
    PERDUE, BE
    JARVIS, W
    JOHNSON, JA
    DOWLING, TC
    POLISH, LB
    SCHWALBE, RS
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) : 250 - 259
  • [8] Rothman KJ, 1986, MODERN EPIDEMIOLOGY
  • [9] SPECIES IDENTITIES OF ENTEROCOCCI ISOLATED FROM CLINICAL SPECIMENS
    RUOFF, KL
    DELAMAZA, L
    MURTAGH, MJ
    SPARGO, JD
    FERRARO, MJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 435 - 437
  • [10] *STAT CORP, 1999, STAT STAT SOFTW 1999